drugset / Trial / NCT07593313
Treatment of Post-Stroke Central Pain
RandomizedParallel-groupSingle-blindTreatment
Summary
To evaluate the short-term analgesic efficacy of stSCS combined with pharmacotherapy compared with pharmacotherapy alone in patients with CPSP, measured by Numerical Rating Scale (NRS) score immediately after treatment.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Amitriptyline | Small molecule | 25 mg | — |
| Background | Amitriptyline | Small molecule | 75 mg | — |
| Background | Duloxetine | Small molecule | 60 mg | — |
| Background | Duloxetine | Small molecule | 120 mg | — |
| Background | Gabapentin | Unknown | 900 mg | — |
| Background | Gabapentin | Unknown | 1800 mg | — |
| Background | Pregabalin | Small molecule | 150 mg | — |
| Background | Pregabalin | Small molecule | 300 mg | — |
Indications
No indication recorded.